Susanna Brauner

Artiklar

Article: EUROPEAN JOURNAL OF NEUROLOGY. 2024;31(1):e16100
Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register-based cohort study
O'Connor L; Malmestrom C; Rodrigues RDS; Brauner S; Wikstrom A-K; Punga AR
Article: NEUROEPIDEMIOLOGY. 2024;58(6):460-469
Long-Term Healthcare Resource Utilization and Costs among Patients with Myasthenia Gravis: A Swedish Nationwide Population-Based Study
Cai Q; Batista AE; Borsum J; Zhang Q; Isheden G; Kunovszki P; Gandhi K; Heerlein K; Brauner S
Article: JAMA NEUROLOGY. 2022;79(11):1105-1112
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis The RINOMAX Randomized Clinical Trial
Piehl F; Eriksson-Dufva A; Budzianowska A; Feresiadou A; Hansson W; Hietala MA; Hakansson I; Johansson R; Jons D; Kmezic I; Lindberg C; Lindh J; Lundin F; Nygren I; Punga AR; Press R; Samuelsson K; Sundstrom P; Wickberg O; Brauner S; Frisell T
Article: NEUROLOGY. 2021;97(14):e1382-e1391
Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort Cross-sectional Analysis of the Swedish GEMG Study
Petersson M; Feresiadou A; Jons D; Ilinca A; Lundin F; Johansson R; Budzianowska A; Roos A-K; Kagstrom V; Gunnarsson M; Sundstrom P; Piehl F; Brauner S
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:667336
Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations
Creary LE; Gangavarapu S; Caillier SJ; Cavalcante P; Frangiamore R; Lie BA; Bengtsson M; Harbo HF; Brauner S; Hollenbach JA; Oksenberg JR; Bernasconi P; Maniaol AH; Hammarstrom L; Mantegazza R; Fernandez-Vina MA
Article: JAMA NEUROLOGY. 2020;77(8):974-981
Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis
Brauner S; Eriksson-Dufva A; Hietala MA; Frisell T; Press R; Piehl F
Article: JOURNAL OF CLINICAL INVESTIGATION. 2020;130(2):838-852
C-type lectin receptors Mcl and Mincle contro development of multiple sclerosis like neuroinflammation
N'diaye M; Brauner S; Flytzani S; Kular L; Warnecke A; Adzemovic MZ; Piket E; Min J-H; Edwards W; Mela F; Choi HY; Magg V; James T; Linden M; Reichardt HM; Daws MR; van Horssen J; Kockum I; Harris RA; Olsson T; Guerreiro-Cacais AO; Jagodic M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2018;194(3):315-326
The Sjogren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production
Brauner S; Ivanchenko M; Thorlacius GE; Ambrosi A; Wahren-Herlenius M
Article: CARDIOVASCULAR RESEARCH. 2018;114(1):158-167
Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content
Brauner S; Jiang X; Thorlacius GE; Lundberg AM; Ostberg T; Yan Z-Q; Kuchroo VK; Hansson GK; Wahren-Herlenius M
Article: BIOLOGY OF SEX DIFFERENCES. 2017;8(1):34
Sex influences eQTL effects of SLE and Sjogren's syndrome-associated genetic polymorphisms
Linden M; Sepulveda JIR; James T; Thorlacius GE; Brauner S; Gomez-Cabrero D; Olsson T; Kockum I; Wahren-Herlenius M
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(10):1755-1763
H1N1 vaccination in Sjogren's syndrome triggers polyclonal B cell activation and promotes autoantibody production
Brauner S; Folkersen L; Kvarnstrom M; Meisgen S; Petersen S; Franzen-Malmros M; Mofors J; Brokstad KA; Klareskog L; Jonsson R; Westerberg LS; Trollmo C; Malmstrom V; Ambrosi A; Kuchroo VK; Nordmark G; Wahren-Herlenius M
Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):139
IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E
Article: BIOLOGY OF SEX DIFFERENCES. 2017;8:16
Difference in clinical presentation between women and men in incident primary Sjogren's syndrome
Sepulveda JIR; Kvarnstrom M; Brauner S; Baldini C; Wahren-Herlenius M
Article: JOURNAL OF INTERNAL MEDICINE. 2015;278(3):323-332
Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease
Brauner S; Zhou W; Backlin C; Green TM; Folkersen L; Ivanchenko M; Lofstrom B; Xu-Monette ZY; Young KH; Pedersen LM; Moller MB; Sundstrom C; Enblad G; Baecklund E; Wahren-Herlenius M
Article: MULTIPLE SCLEROSIS JOURNAL. 2014;20(13):1727-1736
Interferon beta treatment of multiple sclerosis increases serum interleukin-7
Lundstrom W; Hermanrud C; Sjostrand M; Brauner S; Wahren-Herlenius M; Olsson T; Karrenbauer V; Hillert J; Fogdell-Hahn A
Article: JOURNAL OF IMMUNOLOGY. 2013;191(7):3753-3763
Expression of the Immune Regulator Tripartite-Motif 21 Is Controlled by IFN Regulatory Factors
Sjostrand M; Ambrosi A; Brauner S; Sullivan J; Malin S; Kuchroo VK; Espinosa A; Wahren-Herlenius M
Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2009;206(8):1661-1671
Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway
Espinosa A; Dardalhon V; Brauner S; Ambrosi A; Higgs R; Quintana FJ; Sjostrand M; Eloranta M-L; Gabhann JN; Winqvist O; Sundelin B; Jefferies CA; Rozell B; Kuchroo VK; Wahren-Herlenius M
Article: LUPUS. 2007;16(1):10-17
Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun
Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
Article: JOURNAL OF IMMUNOLOGY. 2006;176(10):6277-6285
The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death
Espinosa A; Zhou W; Ek M; Hedlund M; Brauner S; Popovic K; Horvath L; Wallerskog T; Oukka M; Nyberg F; Kuchroo VK; Wahren-Herlenius M
Article: MOLECULAR IMMUNOLOGY. 2006;43(6):588-598
Structural, functional and immunologic characterization of folded subdomains in the Ro52, protein targeted in Sjogren's syndrome
Ottosson L; Hennig J; Espinosa A; Brauner S; Wahren-Herlenius M; Sunnerhagen M

Alla övriga publikationer

Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(12):1840-1842
Clinical associations and expression pattern of the autoimmunity susceptibility factor DIORA-1 in patients with primary Sjogren's syndrome
Aqrawi LA; Mentlein L; Meneghel L; Bjork A; Thorlacius GE; Ivanchenko M; Sepulveda JIR; Skarstein K; Kvarnstrom M; Brauner S; Espinosa A; Wahren-Herlenius M
Letter: EXPERIMENTAL DERMATOLOGY. 2017;26(5):444-446
IL-22 binding protein regulates murine skin inflammation
Lindahl H; Martini E; Brauner S; Nikamo P; Serezal IG; Guerreiro-Cacais AO; Jagodic M; Eidsmo L; Stahle M; Olsson T
Doctoral thesis: 2013
TRIM21/ Ro52 in B cell pathology
Brauner S
Letter: JOURNAL OF IMMUNOLOGY. 2009;183(12):7620-7621
Comment on "Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-κB-Dependent Cytokine Expression in Fibroblasts Response
Espinosa A; Brauner S; Ambrosi A; Kuchroo V; Wahren-Herlenius M

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI